Cited by 78Reproductive Health and ContraceptionDiabetes, Cardiovascular Risks, and LipoproteinsLipoproteins and Cardiovascular Health

Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population

Morin-Papunen, Laure, Martikainen, Hannu, McCarthy, Mark I., Franks, Stephen, Sovio, Ulla, Hartikainen, Anna-Liisa, Ruokonen, Aimo, Leinonen, Maija +3 more·2008·American Journal of Obstetrics and Gynecology

Abstract

Objective We compared the metabolic and cardiovascular parameters of a reference group of women with those of women who used 2 contraceptive regimes that are used worldwide: the levonorgestrel-releasing intrauterine device and oral contraceptives.Study design We investigated a cohort of 2814 women at age 31 years from the general population-based Northern Finland Birth Cohort who were born in 1966. Women were classified as oral contraceptive users (n = 687 women), levonorgestrel-releasing intrauterine device users (n = 168 women), or no use of hormonal contraception (reference group; n = 1959 women). The analyses were adjusted for body mass index, current alcohol use, household income, and area of residence.Results Compared with the reference group, oral contraceptive users had higher systolic and diastolic blood pressure, raised levels of inflammatory indices (C-reactive protein), and impaired insulin sensitivity. Levonorgestrel-releasing intrauterine device users displayed a lower high-density lipoprotein and total cholesterol, but a similar cholesterol/ high-density lipoprotein ratio, and higher leukocyte count compared with the reference group. Oral contraception users were insulin-resistant compared with levonorgestrel-releasing intrauterine device users with higher blood pressure, raised lipid levels (such as total cholesterol and triglycerides) and insulin levels, and lower homeostasis model assessment and insulin sensitivity, despite smaller waist and lower waist-hip ratio.Conclusion Oral contraception usage was associated with adverse findings in several metabolic, cardiovascular, and inflammatory parameters, which is consistent with an increased future risk of cardiovascular and metabolic disease. These findings should invite more criticism of recent trends that encourage the prescription of oral contraceptives for years during reproductive life and especially in premenopausal women. In contrast, levonorgestrel-releasing intrauterine device or progestin-only pills may offer long-term health benefits over oral contraceptives and should be preferred to oral contraceptives for women in their forties and/or with metabolic risk factors for cardiovascular diseases and type 2 diabetes mellitus.

Integrity signals

Registry

Crossref · 10.1016/j.ajog.2008.04.013

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

1 of the 48 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Morin-Papunen, L., Martikainen, H., McCarthy, M. I., Franks, S., Sovio, U., Hartikainen, A.-L., Ruokonen, A., Leinonen, M., Laitinen, J., Järvelin, M.-R., & Pouta, A.
Affiliations
  • Oulu University Hospital (FI)
  • Oxford Centre for Diabetes, Endocrinology and Metabolism (GB)
  • Imperial College London (GB)
  • Finnish Institute of Occupational Health (FI)
Venue
American Journal of Obstetrics and Gynecology
Publisher
Elsevier BV
Published
2008-11
Volume
199
Issue
5
Pages
529.e1-529.e10
ISSN
0002-9378 (ISSN-L)
OpenAlex
W2094977869
Cited by
78
References
48
Citations by year
2026: 5 · 2025: 1 · 2024: 4 · 2023: 3 · 2022: 4 · 2021: 2 · 2020: 4 · 2019: 5 · 2018: 1 · 2017: 5 · 2016: 7 · 2014: 3 · 2013: 4 · 2012: 5
FWCI
8.28
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Obstetrics and Gynecology (publishedVersion)
  • PubMed (publishedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (submittedVersion)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
Keywords
oral contraceptives, levonorgestrel-releasing intrauterine system, hormonal contraception, insulin resistance, C-reactive protein, inflammation, blood pressure, lipid profile, cardiovascular risk, type 2 diabetes risk, metabolic risk factors, women's health
MeSH terms
Adult, Blood Pressure, C-Reactive Protein, Cardiovascular Diseases, Cholesterol, Contraceptive Agents, Female, Contraceptives, Oral, Diabetes Mellitus, Type 2, Female, Homeostasis, Humans, Inflammation, Insulin, Insulin Resistance, Intrauterine Devices, Medicated, Leukocyte Count, Lipids, Lipoproteins, HDL, Metabolic Diseases, Progestins, Levonorgestrel, Waist-Hip Ratio

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review